NasdaqCM - Nasdaq Real Time Price USD
Cardio Diagnostics Holdings, Inc. (CDIO)
4.3898
+0.5498
+(14.32%)
As of 3:42:01 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -1.8 | -1.8 | -6.9 | 0 |
| Low Estimate | -1.8 | -1.8 | -6.9 | 0 |
| High Estimate | -1.8 | -1.8 | -6.9 | 0 |
| Year Ago EPS | -1.8 | -1.8 | -9.3 | -6.9 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | 75k | 150k | 525k | -- |
| Low Estimate | 75k | 150k | 525k | -- |
| High Estimate | 75k | 150k | 525k | -- |
| Year Ago Sales | 7.87k | 6.58k | 34.89k | -- |
| Sales Growth (year/est) | 852.99% | 2,179.64% | 1,404.73% | -- |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -2.7 | -1.5 | -1.8 | -1.8 |
| EPS Actual | -1.8 | -1.8 | -0.3 | -0.97 |
| Difference | 0.9 | -0.3 | 1.5 | 0.83 |
| Surprise % | 33.33% | -20.00% | 83.33% | 46.11% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.8 | -1.8 | -6.9 | 0 |
| 7 Days Ago | -1.8 | -1.8 | -7.5 | 0 |
| 30 Days Ago | -1.8 | -1.8 | -7.5 | 0 |
| 60 Days Ago | -1.8 | -1.8 | -7.5 | 0 |
| 90 Days Ago | -1.8 | -1.8 | -7.5 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CDIO | 0.00% | 0.00% | 25.81% | -- |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 8/27/2024 |
| Maintains | Benchmark: Speculative Buy to Speculative Buy | 6/6/2024 |
| Maintains | Benchmark: Speculative Buy to Speculative Buy | 4/19/2024 |
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 6/15/2023 |
| Initiated | Northland Capital Markets: Outperform | 5/22/2023 |
| Reiterates | Benchmark: Speculative Buy | 4/18/2023 |
Related Tickers
ZVSA ZyVersa Therapeutics, Inc.
0.5161
-1.30%
SPRC SciSparc Ltd.
0.3065
-2.64%
HEPA Hepion Pharmaceuticals, Inc.
0.1050
-4.93%
RNAZ TransCode Therapeutics, Inc.
6.59
-19.24%
CYCC Cyclacel Pharmaceuticals, Inc.
1.9200
-4.00%
PLRZ Polyrizon Ltd.
0.0069
+4.55%
NCNA NuCana plc
0.0480
+9.57%
XLO Xilio Therapeutics, Inc.
0.8835
+2.80%
CNSP CNS Pharmaceuticals, Inc.
1.2900
+0.78%
VOR Vor Biopharma Inc.
0.1728
-2.32%